Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study by Fizazi, Karim, Prof, Carducci, Michael, MD, Smith, Matthew, MD, Damião, Ronaldo, Prof, Brown, Janet, MD, Karsh, Lawrence, MD, Milecki, Piotr, MD, Shore, Neal, MD, Rader, Michael, MD, Wang, Huei, PhD, Jiang, Qi, PhD, Tadros, Sylvia, MPH, Dansey, Roger, MD, Goessl, Carsten, MD

Get full text